Abstract
Malaria remains a significant global health issue, with millions of cases and hundreds of thousands of deaths annually, predominantly caused by Plasmodium falciparum (Pf) and Plasmodium vivax (Pv). Control efforts are complicated by emerging drug resistance, particularly against artemisinin-based treatments (ACTs). While artemisinin resistance is primarily observed in Southeast Asia, the …